Cargando…

Characterisation of the tumour suppressor gene ZAC in breast tissue

Detalles Bibliográficos
Autores principales:	Valleley, EM, Cordery, SF, Shires, M, Speirs, V, Bonthron, DT
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300250/ http://dx.doi.org/10.1186/bcr1558

Ejemplares similares

A tissue-specific promoter derived from a SINE retrotransposon drives biallelic expression of PLAGL1 in human lymphocytes
por: Smith, Claire E. L., et al.
Publicado: (2017)

Sequence analysis and editing for bisulphite genomic sequencing projects
por: Carr, Ian M., et al.
Publicado: (2007)

Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009)

NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene
por: Chua, Y-L, et al.
Publicado: (2008)

Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
por: Stone, A, et al.
Publicado: (2008)

Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells
por: Verghese, E, et al.
Publicado: (2008)

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
por: Janssen, Nicole, et al.
Publicado: (2015)

Zac1 regulates IL-11 expression in osteoarthritis
por: Kuo, Chun-Lin, et al.
Publicado: (2018)

Evolutionary conservation of Zinc-Activated Channel (ZAC) functionality in mammals: a range of mammalian ZACs assemble into cell surface-expressed functional receptors
por: Jensen, Anders A.
Publicado: (2023)

MFSD2A is a novel lung tumour suppressor gene whose expression is modulated by a 5’-region polymorphism
por: Colombo, Francesca, et al.
Publicado: (2010)

Mri functional and tissue characterisation in patients with systemic lupus erythematosus
por: Gruber, Angela, et al.
Publicado: (2011)

MRI functional and tissue characterisation in patients with systemic lupus erythematosus
por: Buss, Sebastian, et al.
Publicado: (2012)

Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis
por: Su, Hui-Chen, et al.
Publicado: (2020)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

P66. Generating and characterising WT1-specific T cells – research towards adoptive tumour therapy
por: Schmied, S, et al.
Publicado: (2014)

Involvement of PLAGL1/ZAC1 in hypocretin/orexin transcription
por: Tanaka, Susumu, et al.
Publicado: (2019)

Characterising an aromatase inhibitor resistant breast cancer cell line
por: Harris, E, et al.
Publicado: (2012)

CYLD tumour supressor regulates ciligenesis
por: Eguether, T, et al.
Publicado: (2012)

Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT
por: Michielsen, K, et al.
Publicado: (2015)

Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53
por: Fourtouna, A, et al.
Publicado: (2006)

Modelling breast cancer in a three-dimensional heterotypic culture system
por: Holliday, DL, et al.
Publicado: (2010)

In vitro characterisation of Spontaneous Mammary Tumour (SMT1) cells and its matched lung metastatic (SMT1L) cells
por: Wong, TC, et al.
Publicado: (2012)

Estudio de la comunidad de Los Corrales Sombrerete, Zac./
por: Colorado León, Pedro
Publicado: (1982)

Non-invasive contrast enhanced MRI tissue characterisation early and late after heart transplantation
por: Steen, Henning, et al.
Publicado: (2012)

Reduced MCPH1 expression in breast cancer and response to chemotherapy
por: Richardson, J, et al.
Publicado: (2010)

Downregulation of 15-hydroxyprostaglandin dehydrogenase in hormone-resistant breast cancer
por: Cummings, M, et al.
Publicado: (2008)

Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome
por: Baptissart, Marine, et al.
Publicado: (2022)

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast
por: Hussain, Zeiad, et al.
Publicado: (2015)

Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer
por: Speirs, V, et al.
Publicado: (2006)

Primary brain tumours following breast cancer
por: Hussain, M, et al.
Publicado: (2015)

Relationship between clinical features and the diagnostic value of CMR tissue characterisation in patients with clinically suspected myocarditis
por: Biesbroek, Stefan P, et al.
Publicado: (2015)

Detection of gene amplification in matched tumour and plasma DNA from breast cancer patients by quantitative PCR
por: Page, K, et al.
Publicado: (2008)

PB.24: Is digital breast tomosynthesis helpful within a symptomatic one-stop breast clinic for characterisation of subtle findings?
por: Bansal, GJ, et al.
Publicado: (2013)

Tissue and plasma putrescine levels in non-survivors of sepsis in a fluid-resuscitated rat model of faecal peritonitis
por: Andreis, DT, et al.
Publicado: (2015)

Identification of molecular apocrine breast tumours by microarray analysis
por: Farmer, P, et al.
Publicado: (2005)

Co-expression of E- and P-cadherin in breast cancer: role as an invasion suppressor or as an invasion promoter?
por: Ribeiro, Ana S, et al.
Publicado: (2010)

Estudio de la comunidad de José María Morelos Sombrerete, Zac/
por: Contreras Hernández, Alvaro
Publicado: (1982)

ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieria Neto, Leonardo, et al.
Publicado: (2013)

Identification of genes involved in the formation of lymph node metastasis from human tumour xenograft models of breast cancer
por: Paon, L, et al.
Publicado: (2008)

Role of the metastasis suppressor tetraspanin CD82/KAI 1 in regulation of signalling in breast cancer cells
por: Odintsova, E, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5906oe061v5c2rjp8ebmlcjflm